Merrimack Pharmaceuticals (NASDAQ:MACK) Stock Rating Upgraded by StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Rating)’s stock price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $9.67 and traded as high as $12.66. Merrimack Pharmaceuticals shares last traded at $12.51, with a volume of 63,141 shares trading hands. Analysts […]